ProShare Advisors LLC - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 165 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$7,000
-36.4%
15,826
+12.8%
0.00%
Q2 2022$11,000
-82.0%
14,025
-70.5%
0.00%
Q1 2022$61,000
-24.7%
47,538
-25.5%
0.00%
Q4 2021$81,000
-38.2%
63,845
+6.1%
0.00%
Q3 2021$131,000
-52.5%
60,176
-18.2%
0.00%
-100.0%
Q2 2021$276,000
+34.0%
73,595
+16.7%
0.00%0.0%
Q1 2021$206,000
+5.6%
63,046
+10.1%
0.00%0.0%
Q4 2020$195,000
+8.9%
57,273
+30.8%
0.00%0.0%
Q3 2020$179,000
+46.7%
43,797
+21.0%
0.00%0.0%
Q2 2020$122,000
+117.9%
36,202
+51.4%
0.00%
Q1 2020$56,000
-63.9%
23,919
-43.9%
0.00%
-100.0%
Q4 2019$155,000
-59.4%
42,649
-7.5%
0.00%
-50.0%
Q3 2019$382,000
-4.5%
46,103
-0.7%
0.00%0.0%
Q2 2019$400,000
-27.7%
46,416
-10.3%
0.00%
-33.3%
Q1 2019$553,000
+27.1%
51,724
+4.1%
0.00%0.0%
Q4 2018$435,000
-55.4%
49,700
-14.4%
0.00%
-57.1%
Q3 2018$975,000
-22.2%
58,041
-2.9%
0.01%
-12.5%
Q2 2018$1,253,000
+28.8%
59,798
-1.1%
0.01%
+33.3%
Q1 2018$973,000
-26.5%
60,456
-13.5%
0.01%
-33.3%
Q4 2017$1,324,000
+72.8%
69,884
+28.4%
0.01%
+28.6%
Q3 2017$766,000
+108.7%
54,430
+10.6%
0.01%
+75.0%
Q2 2017$367,000
+5.5%
49,211
-8.1%
0.00%0.0%
Q1 2017$348,000
+16.8%
53,568
-20.3%
0.00%
+33.3%
Q4 2016$298,000
+7.2%
67,226
+13.0%
0.00%
-25.0%
Q3 2016$278,000
-30.7%
59,478
-2.6%
0.00%
-20.0%
Q2 2016$401,000
+5.0%
61,073
+1.8%
0.01%0.0%
Q1 2016$382,000
-3.0%
60,019
-8.2%
0.01%0.0%
Q4 2015$394,000
+11.9%
65,378
+11.1%
0.01%0.0%
Q3 2015$352,000
-18.3%
58,837
-6.7%
0.01%
-16.7%
Q2 2015$431,000
+5.6%
63,053
-6.2%
0.01%
+20.0%
Q1 2015$408,0000.0%67,209
+14.1%
0.01%0.0%
Q4 2014$408,000
-18.1%
58,908
-3.7%
0.01%
-28.6%
Q3 2014$498,000
-16.9%
61,173
-17.0%
0.01%
-12.5%
Q2 2014$599,000
-33.1%
73,683
-35.5%
0.01%
-27.3%
Q1 2014$896,000
+202.7%
114,250
+241.7%
0.01%
+175.0%
Q4 2013$296,000
-44.6%
33,439
-47.4%
0.00%
-69.2%
Q3 2013$534,000
+36.9%
63,593
+21.7%
0.01%
+62.5%
Q2 2013$390,00052,2380.01%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 787,973$615,0000.77%
CM Management, LLC 600,000$468,0000.50%
ARMISTICE CAPITAL, LLC 17,100,000$13,338,0000.23%
Sargent Investment Group, LLC 614,600$479,0000.15%
Ergoteles LLC 744,275$581,0000.02%
Sonora Investment Management Group, LLC 103,000$80,0000.01%
CAXTON ASSOCIATES LP 107,135$84,0000.01%
MCDONALD PARTNERS LLC 42,570$33,0000.01%
Pinz Capital Management, LP 15,600$12,0000.01%
D. E. Shaw & Co., Inc. 8,051,858$6,281,0000.01%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders